| 中文名称 | 锌原卟啉 |
| 英文名称 | PROTOPORPHYRINATO ZINC |
| CAS号 | 15442-64-5 |
| 分子式 | C34H31N4O4Zn- |
| 分子量 | 625.03 |
| EINECS号 | 239-455-7 |
| 溶解度 | DMSO：50 mg/mL（79.87 mM；需要超声波）H2O：< 0.1 mg/mL（不溶） |
| 形态 | 结晶 |
| 颜色 | 暗红色至紫色 |
| 水溶解性 | Insoluble in water. Soluble in ethanol, and DMSO, pyridine, or dimethyl formamide. |
| 稳定性 | 吸湿性 |
| WGK Germany | 3 |
| RTECS号 | ZG9210300 |
| TSCA | Yes |
|
Human Endogenous Metabolite
|
Zinc Protoporphyrin (Zn(II)-protoporphyrin IX; 5 μM; 72 hours) causes the fraction of late apoptotic and necrotic cells increasing from 10.9% in controls to 30.4% after 72 h.
Zinc Protoporphyrin (1.25-40 μM; 48 or 72 hours) exerts cystostatic/cytotoxic effects against tumor cells.
Zinc Protoporphyrin (2.5, 5 μM; 48 or 72 hours) results in dose- and time-dependent reduction of cells in G1 phase of the cell cycle.
Zinc Protoporphyrin (1.25-40 μM; 48 hours) leads to accumulation of cleaved (active) caspase-3.
Apoptosis Analysis
| Cell Line: | C-26 cells |
| Concentration: | 5 μM |
| Incubation Time: | 72 hours |
| Result: | The fraction of late apoptotic and necrotic cells increased from 10.9% in controls to 30.4% after 72 h. |
Cell Cytotoxicity Assay
| Cell Line: | C-26 and MDA-MB231 cells |
| Concentration: | 1.25, 2.5, 5, 10, 20, 40 μM |
| Incubation Time: | 48 or 72 hours |
| Result: | Exerted cystostatic/cytotoxic effects against tumor cells. |
Cell Cycle Analysis
| Cell Line: | C-26 cells |
| Concentration: | 2.5, 5 μM |
| Incubation Time: | 48 or 72 hours |
| Result: | Resulted in dose- and time-dependent reduction of cells in G1 phase of the cell cycle. |
Western Blot Analysis
| Cell Line: | C-26 cells |
| Concentration: | 1.25, 2.5, 5, 10, 20, 40 μM |
| Incubation Time: | 48 hours |
| Result: | Leaded to accumulation of cleaved (active) caspase-3. |
Zinc Protoporphyrin (12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o.; from day 7 to 19) exerts dose-dependent antitumor effects manifested by the retardation of tumor growth.
| Animal Model: | BALB/c mice inoculated with C-26 cells |
| Dosage: | 12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o. |
| Administration: | IP or PO; from day 7 to 19 |
| Result: | Exerted dose-dependent antitumor effects manifested by the retardation of tumor growth. |
-
CAS号:553-12-8
原卟啉 -
CAS号:35194-36-6
4-己烯酸 -
CAS号:625-84-3
2,5-二甲基吡咯 -
CAS号:625-82-1
2,4-二甲基吡咯 -
CAS号:1003-90-3
2,3,4,5-四甲基吡咯 -
CAS号:2524-49-4
3-丁烯-1-胺 -
CAS号:1119-60-4
6-庚酸 -
CAS号:19154-63-3
硝酸锌四水合物 -
CAS号:591-80-0
4-戊烯酸 -
CAS号:15442-64-5
锌原卟啉 -
CAS号:553-12-8
原卟啉 -
CAS号:35194-36-6
4-己烯酸 -
CAS号:625-84-3
2,5-二甲基吡咯 -
CAS号:625-82-1
2,4-二甲基吡咯 -
CAS号:1003-90-3
2,3,4,5-四甲基吡咯 -
CAS号:2524-49-4
3-丁烯-1-胺 -
CAS号:1119-60-4
6-庚酸 -
CAS号:19154-63-3
硝酸锌四水合物 -
CAS号:591-80-0
4-戊烯酸 -
CAS号:15442-64-5
锌原卟啉